SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.850-2.6%Nov 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Kirk ©
mattstat
To: drkaz who wrote (10323)5/23/2018 12:45:31 PM
From: romanoff2 Recommendations  Read Replies (1) of 12871
 
It has been my concern for some time that NNVC's biggest problem is its inability to manufacture large, consistent quantities of product. That's what stopped flucide and so far seems to have stopped herpecide. If that's the case, I don't understand why Diwan hasn't allied with another pharmaceutical company that has that capability. I'm afraid his dithering will be the ruination of his company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext